Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Chronic thromboembolic pulmonary hypertension.

P F Fedullo1, K M Kerr, W R Auger

  • 1Pulmonary and Critical Care Division, University of California, San Diego, USA.

Seminars in Respiratory and Critical Care Medicine
|August 10, 2005
PubMed
Summary

Chronic thromboembolic pulmonary hypertension is a correctable condition. Pulmonary thromboendarterectomy procedures have improved, with reduced mortality, but further research is needed for diagnosis and complications.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Early and locally advanced non-small-cell lung cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up.

Annals of oncology : official journal of the European Society for Medical Oncology·2025
Same author

Antibody-drug conjugates in lung and breast cancer: current evidence and future directions-a position statement from the ETOP IBCSG Partners Foundation.

Annals of oncology : official journal of the European Society for Medical Oncology·2024
Same author

Pathologist-initiated reflex testing for biomarkers in non-small-cell lung cancer: expert consensus on the rationale and considerations for implementation.

ESMO open·2023
Same author

Oncogene-addicted metastatic non-small-cell lung cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up.

Annals of oncology : official journal of the European Society for Medical Oncology·2023
Same author

Non-oncogene-addicted metastatic non-small-cell lung cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up.

Annals of oncology : official journal of the European Society for Medical Oncology·2023
Same author

Management of toxicities from immunotherapy: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.

Annals of oncology : official journal of the European Society for Medical Oncology·2018

Area of Science:

  • Cardiology
  • Pulmonary Medicine
  • Surgical Innovation

Background:

  • Pulmonary hypertension often presents challenges in treatment.
  • Chronic thromboembolic pulmonary hypertension (CTEPH) is a potentially curable form.
  • Surgical intervention, specifically pulmonary thromboendarterectomy, is a key treatment.

Purpose of the Study:

  • To review the current status of pulmonary thromboendarterectomy for CTEPH.
  • To highlight advances in surgical outcomes and management.
  • To identify areas requiring further investigation in CTEPH.

Main Methods:

  • Review of worldwide thromboendarterectomy procedures.
  • Analysis of mortality rates from experienced surgical programs.
  • Examination of factors contributing to improved surgical outcomes.

Related Experiment Videos

Main Results:

  • Over 1500 pulmonary thromboendarterectomy procedures have been performed globally.
  • Mortality rates in experienced centers have decreased to 6-8%.
  • Improvements attributed to better preoperative evaluation, surgical expertise, and understanding of postoperative issues.

Conclusions:

  • Pulmonary thromboendarterectomy is a successful treatment for CTEPH, with improving outcomes.
  • Further research is essential to understand disease mechanisms and address complications like reperfusion pulmonary edema.
  • Enhanced diagnostic methods and therapeutic strategies are needed for optimal patient care.